$49.68
0.992.03%
At Close: -
$49.68
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Comments
Loading...
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Cognex (NASDAQ:CGNX) Stock, Analyst Ratings, Price Targets, Forecasts
Cognex Corp has a consensus price target of $51.38 based on the ratings of 19 analysts. The high is $75 issued by Daiwa Capital on January 25, 2022. The low is $41 issued by Goldman Sachs on May 6, 2024. The 3 most-recent analyst ratings were released by Vertical Research, Truist Securities, and HSBC on July 23, 2024, July 2, 2024, and May 7, 2024, respectively. With an average price target of $55 between Vertical Research, Truist Securities, and HSBC, there's an implied 10.71% upside for Cognex Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Vertical Research
Truist Securities
HSBC
Goldman Sachs
Stephens & Co.
1calculated from analyst ratings
Analyst Ratings for Cognex
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/23/2024 | Buy Now | 16.75% | Vertical Research | Kevin McCarthy | → $58 | Initiates | → Buy | Get Alert |
| 07/02/2024 | Buy Now | 10.71% | Truist Securities | Jamie Cook | $50 → $55 | Maintains | Buy | Get Alert |
| 05/07/2024 | Buy Now | 4.67% | HSBC | Helen Fang | → $52 | Upgrade | Hold → Buy | Get Alert |
| 05/07/2024 | Buy Now | 0.64% | Truist Securities | Jamie Cook | $47 → $50 | Reiterates | Buy → Buy | Get Alert |
| 05/06/2024 | Buy Now | -17.47% | Goldman Sachs | Joe Ritchie | $36 → $41 | Maintains | Sell | Get Alert |
| 05/03/2024 | Buy Now | -9.42% | Stephens & Co. | Tommy Moll | $40 → $45 | Maintains | Equal-Weight | Get Alert |
| 05/03/2024 | Buy Now | 10.71% | Bernstein | Jay Huang | $52 → $55 | Maintains | Outperform | Get Alert |
| 05/03/2024 | Buy Now | -3.38% | Needham | James Ricchiuti | $46 → $48 | Maintains | Buy | Get Alert |
| 05/03/2024 | Buy Now | -11.43% | Baird | Richard Eastman | $40 → $44 | Maintains | Neutral | Get Alert |
| 04/08/2024 | Buy Now | -13.45% | Citigroup | Piyush Avasthy | $41 → $43 | Maintains | Neutral | Get Alert |
| 03/19/2024 | Buy Now | 8.7% | UBS | Damian Karas | $42 → $54 | Upgrade | Neutral → Buy | Get Alert |
| 03/14/2024 | Buy Now | -5.39% | Truist Securities | Jamie Cook | → $47 | Initiates | → Buy | Get Alert |
| 11/06/2023 | Buy Now | 20.77% | Raymond James | Brian Gesuale | $65 → $60 | Maintains | Strong Buy | Get Alert |
| 11/02/2023 | Buy Now | -19.48% | Stephens & Co. | Tommy Moll | $55 → $40 | Maintains | Equal-Weight | Get Alert |
| 11/01/2023 | Buy Now | -7.41% | Needham | James Ricchiuti | $55 → $46 | Maintains | Buy | Get Alert |
| 10/10/2023 | Buy Now | -19.48% | Goldman Sachs | Joe Ritchie | $45 → $40 | Maintains | Sell | Get Alert |
| 10/03/2023 | Buy Now | — | Keybanc | Ken Newman | — | Initiates | → Sector Weight | Get Alert |
| 09/01/2023 | Buy Now | 10.71% | Needham | James Ricchiuti | → $55 | Reiterates | Buy → Buy | Get Alert |
| 08/30/2023 | Buy Now | 4.67% | Citigroup | Piyush Avasthy | → $52 | Initiates | → Neutral | Get Alert |
| 08/07/2023 | Buy Now | -7.41% | Credit Suisse | Guy Hardwick | $47 → $46 | Maintains | Neutral | Get Alert |
| 08/04/2023 | Buy Now | -7.41% | Morgan Stanley | Joshua Pokrzywinski | $45 → $46 | Maintains | Underweight | Get Alert |
| 08/03/2023 | Buy Now | 10.71% | Needham | James Ricchiuti | $58 → $55 | Maintains | Buy | Get Alert |
| 07/13/2023 | Buy Now | -5.39% | Credit Suisse | Guy Hardwick | $46 → $47 | Maintains | Neutral | Get Alert |
| 06/20/2023 | Buy Now | -5.39% | Stephens & Co. | Tommy Moll | → $47 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 05/09/2023 | Buy Now | -7.41% | Credit Suisse | Guy Hardwick | $44 → $46 | Maintains | Neutral | Get Alert |
| 05/05/2023 | Buy Now | -9.42% | Morgan Stanley | Joshua Pokrzywinski | $40 → $45 | Maintains | Underweight | Get Alert |
| 05/05/2023 | Buy Now | 16.75% | Needham | James Ricchiuti | → $58 | Reiterates | → Buy | Get Alert |
| 02/23/2023 | Buy Now | -11.43% | Credit Suisse | Guy Hardwick | $41 → $44 | Upgrade | Underperform → Neutral | Get Alert |
| 02/21/2023 | Buy Now | -9.42% | Stephens & Co. | Tommy Moll | → $45 | Reiterates | → Equal-Weight | Get Alert |
| 02/17/2023 | Buy Now | 16.75% | Needham | James Ricchiuti | $54 → $58 | Maintains | Buy | Get Alert |
| 02/01/2023 | Buy Now | — | Northcoast Research | Tom Hayes | — | Downgrade | Buy → Neutral | Get Alert |
| 01/17/2023 | Buy Now | -19.48% | Morgan Stanley | Joshua Pokrzywinski | $41 → $40 | Downgrade | Equal-Weight → Underweight | Get Alert |
| 12/13/2022 | Buy Now | -17.47% | Credit Suisse | Guy Hardwick | → $41 | Initiates | → Underperform | Get Alert |
| 11/22/2022 | Buy Now | 0.64% | Cowen & Co. | Joseph Giordano | $55 → $50 | Downgrade | Outperform → Market Perform | Get Alert |
| 11/07/2022 | Buy Now | 30.84% | Raymond James | Brian Gesuale | $75 → $65 | Maintains | Strong Buy | Get Alert |
| 11/04/2022 | Buy Now | 8.7% | Needham | James Ricchiuti | $52 → $54 | Maintains | Buy | Get Alert |
| 10/12/2022 | Buy Now | -17.47% | Morgan Stanley | Joshua Pokrzywinski | $45 → $41 | Maintains | Equal-Weight | Get Alert |
| 09/20/2022 | Buy Now | 4.67% | Needham | James Ricchiuti | $50 → $52 | Maintains | Buy | Get Alert |
| 08/12/2022 | Buy Now | — | JP Morgan | Paul Chung | — | Downgrade | Neutral → Underweight | Get Alert |
| 08/04/2022 | Buy Now | -9.42% | Morgan Stanley | Joshua Pokrzywinski | $52 → $45 | Maintains | Equal-Weight | Get Alert |
| 08/03/2022 | Buy Now | 10.71% | Cowen & Co. | Joseph Giordano | $75 → $55 | Maintains | Outperform | Get Alert |
| 08/03/2022 | Buy Now | 50.97% | Raymond James | Brian Gesuale | $80 → $75 | Maintains | Strong Buy | Get Alert |
| 08/03/2022 | Buy Now | 30.84% | Bernstein | Jay Huang | → $65 | Upgrade | Market Perform → Outperform | Get Alert |
| 08/03/2022 | Buy Now | -9.42% | Stephens & Co. | Tommy Moll | $80 → $45 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 08/03/2022 | Buy Now | 0.64% | Needham | James Ricchiuti | $60 → $50 | Maintains | Buy | Get Alert |
| 08/01/2022 | Buy Now | 20.77% | Needham | James Ricchiuti | $80 → $60 | Maintains | Buy | Get Alert |
| 06/23/2022 | Buy Now | -17.47% | Goldman Sachs | Joe Ritchie | $59 → $41 | Maintains | Sell | Get Alert |
| 06/09/2022 | Buy Now | 61.03% | Raymond James | Brian Gesuale | $90 → $80 | Maintains | Strong Buy | Get Alert |
| 05/31/2022 | Buy Now | 4.67% | Morgan Stanley | Joshua Pokrzywinski | $68 → $52 | Maintains | Equal-Weight | Get Alert |
| 05/26/2022 | Buy Now | 0.64% | UBS | Markus Mittermaier | $80 → $50 | Maintains | Neutral | Get Alert |
| 05/09/2022 | Buy Now | 81.16% | Raymond James | Brian Gesuale | $110 → $90 | Maintains | Strong Buy | Get Alert |
| 05/06/2022 | Buy Now | 36.88% | Morgan Stanley | Joshua Pokrzywinski | $80 → $68 | Maintains | Equal-Weight | Get Alert |
| 05/06/2022 | Buy Now | 61.03% | Needham | James Ricchiuti | $95 → $80 | Maintains | Buy | Get Alert |
| 04/07/2022 | Buy Now | 61.03% | Morgan Stanley | Joshua Pokrzywinski | $75 → $80 | Maintains | Equal-Weight | Get Alert |
| 03/07/2022 | Buy Now | 34.86% | Goldman Sachs | Joe Ritchie | $77 → $67 | Maintains | Sell | Get Alert |
| 02/18/2022 | Buy Now | 50.97% | Morgan Stanley | Joshua Pokrzywinski | $83 → $75 | Maintains | Equal-Weight | Get Alert |
| 02/18/2022 | Buy Now | 36.88% | JP Morgan | Paul Chung | $80 → $68 | Upgrade | Underweight → Neutral | Get Alert |
| 01/25/2022 | Buy Now | 50.97% | Daiwa Capital | Jairam Nathan | $81 → $75 | Upgrade | Neutral → Outperform | Get Alert |
| 01/14/2022 | Buy Now | 67.07% | Morgan Stanley | Joshua Pokrzywinski | $85 → $83 | Maintains | Equal-Weight | Get Alert |
| 11/12/2021 | Buy Now | 101.29% | Cowen & Co. | Joseph Giordano | — | Maintains | Outperform | Get Alert |
| 11/12/2021 | Buy Now | 71.1% | Morgan Stanley | Joshua Pokrzywinski | — | Upgrade | Underweight → Equal-Weight | Get Alert |
| 11/08/2021 | Buy Now | — | Northcoast Research | Tom Hayes | — | Upgrade | Neutral → Buy | Get Alert |
| 11/08/2021 | Buy Now | 91.22% | Needham | James Ricchiuti | — | Upgrade | Hold → Buy | Get Alert |
| 11/08/2021 | Buy Now | 121.42% | Raymond James | Brian Gesuale | — | Maintains | Strong Buy | Get Alert |
| 10/07/2021 | Buy Now | 48.95% | Morgan Stanley | Joshua Pokrzywinski | — | Maintains | Underweight | Get Alert |
FAQ
What is the target price for Cognex (CGNX) stock?
The latest price target for Cognex (NASDAQ:CGNX) was reported by Vertical Research on July 23, 2024. The analyst firm set a price target for $58.00 expecting CGNX to rise to within 12 months (a possible 16.75% upside). 22 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Cognex (CGNX)?
The latest analyst rating for Cognex (NASDAQ:CGNX) was provided by Vertical Research, and Cognex initiated their buy rating.
When was the last upgrade for Cognex (CGNX)?
The last upgrade for Cognex Corp happened on May 7, 2024 when HSBC raised their price target to $52. HSBC previously had a hold for Cognex Corp.
When was the last downgrade for Cognex (CGNX)?
The last downgrade for Cognex Corp happened on February 1, 2023 when Northcoast Research changed their price target from N/A to N/A for Cognex Corp.
When is the next analyst rating going to be posted or updated for Cognex (CGNX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cognex, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cognex was filed on July 23, 2024 so you should expect the next rating to be made available sometime around July 23, 2025.
Is the Analyst Rating Cognex (CGNX) correct?
While ratings are subjective and will change, the latest Cognex (CGNX) rating was a initiated with a price target of $0.00 to $58.00. The current price Cognex (CGNX) is trading at is $49.68, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.